变应性鼻炎的非特异性免疫治疗进展

张樊苹; 佘翠萍

doi:10.13201/j.issn.1001-1781.2013.15.020

变应性鼻炎的非特异性免疫治疗进展

张樊苹,
佘翠萍^,

- 大连医科大学附属大连市中心医院耳鼻咽喉头颈外科(辽宁大连, 116033)

详细信息

通讯作者: 佘翠萍,E-mail:dlscp@tom.com

中图分类号: R765.21

收稿日期: 2013-01-24

The progress of the nonspecific immune therapy of allergic rhinitis

ZHANG Fanping,
SHE Cuiping^,

More Information

Corresponding author: SHE Cuiping, E-mail: dlscp@tom.com

Received Date: 24 January 2013

摘要

- 鼻炎,变应性 /
- 免疫调节 /
- 非特异性免疫治疗
Abstract: The article describes immune disorder mechanisms of allergic rhinitis and the progress and clinical application status of the nonspecific immune therapy of allergic rhinitis,which can raise people′s understanding about the nonspecific immune therapy of this disease.
- rhinitis,allergic /
- immune modulation /
- nonspecific immune therapy

HTML全文

参考文献(24)

[1]	中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科分会. AR诊断和治疗指南(2009年,武夷山)[J].中华耳鼻咽喉头颈外科杂志,2009,44(12):977-978.
[2]	CINGI C, KAYABASOGLU G, NACAR A. Update on the medical treatment of allergic rhinitis[J]. Inflamm Allergy Drug Targets, 2009, 8:96-103.
[3]	COX L, WALLACE D. Specific allergy immunotherapy for allergic rhinitis:subcutaneous and sublingual[J]. Immunol Allergy Clin North Am,2011,31:561-599.
[4]	RICHTER D. Allergic rhinitis in children[J]. Acta Med Croatica, 2011, 65:163-168.
[5]	SMALL P, KIM H. Allergic rhinitis[J]. Allergy Asthma Clin Immunol, 2011, 7, Suppl 1:p. S3.
[6]	NGUYEN T H, CASALE T B. Immune modulation for treatment of allergic disease[J]. Immunol Rev,2011,242:258-271.
[7]	BORISH L C,NELSON H S, CORREN J, et al. Efficacy of soluble IL-4 receptor for the treatment of adults with asthma[J]. J Allergy Clin Immunol, 2001, 107:963-970.
[8]	HART T K, BLACKBURN M N, BRIGHAM-BURKEM, et al. Preclinical efficacy and safety of pascolizumab (SB 240683):a humanized anti-interleukin-4 antibody with therapeutic potential in asthma[J]. Clin Exp Immunol, 2002, 130:93-100.
[9]	ANTONIU S A. Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema[J]. Curr Opin Investig Drugs, 2010, 11:1286-1294.
[10]	GAUVREAU G M, BOULET L P, COCKCROFT D W, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma[J]. Am J Respir Crit Care Med, 2011, 183:1007-1014.
[11]	ANTONIU S A. MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma[J]. Curr Opin Mol Ther, 2010, 12:233-239.
[12]	SHIMIZU S, HATTORI R, MAJIMA Y, et al. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats[J]. Ann Otol Rhinol Laryngol, 2009, 118:67-72.
[13]	WOERLY G, HONDA K, LOYENS M, et al. Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation[J].J Exp Med, 2003, 198:411-421.
[14]	KUPRYS-LIPINSKA I, KUNA P.[Omalizumab, recombinant humanized monoclonal antibody anti-IgE-new fields of studies on the therapeutic indications] [J]. Pneumonol Alergol Pol, 2009, 77:43-51.
[15]	PETTIPHER R, HANSEL T T. Antagonists of the prostaglandin D2 receptor CRTH2. Drug News Perspect, 2008. 21(6):p. 317-22.
[16]	BARNES N, PAVOR I, CHUCHALIN A, et al. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma[J]. Clin Exp Allergy, 2012, 42:38-48.
[17]	MASUDA E S, SCHMITZ J. Syk inhibitors as treatment for allergic rhinitis[J]. Pulm Pharmacol Ther, 2008, 21:461-467.
[18]	FRANSSON M,ADNER M,ERJEFALT J,et al. Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Respir Res, 2005. 6:p. 100.
[19]	GUPTA G K,AGRAWAL D K. CpG oligodeoxynucleotides as TLR9 agonists:therapeutic application in allergy and asthma[J]. BioDrugs,2010,24:225-235.
[20]	TANG S,ZHAO B,ZHANG G,et al.[Immune modulatory and therapeutic effect of BCG polysaccharides nucleic acid on perennial allergic rhinitis] [J]. Lin Chuang Er Bi Yan Hou Ke Za Zhi, 2005,19:345-346.
[21]	HU J,CHEN H. The effect of BCG-PSN on T-cell subsets and cytokines in vernal conjunctivitis[J]. J Huazhong Univ Sci Technolog Med Sci,2002,22:77-79.
[22]	LI J,LUO D F,LI S Y,et al. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis:a randomized, double blind, placebo-controlled study[J]. Chin Med J (Engl), 2005, 118:1595-1603.
[23]	PUGGIONI F, DURHAM S R, FFANCIS J N. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses[J]. Allergy, 2005, 60:678-684.
[24]	Won T B, QUAN S H, KIM D Y, et al. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate:a novel allergen-independent intranasal vaccine for allergic rhinitis[J]. Ann Allergy Asthma Immunol, 2009, 102:314-322.